Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl Transdermal Matrix Patch in Chronic Intractable Pain
NCT00216684Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2005
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fentanyl in Intractable Pain Syndrome (IPS), sponsored by Janssen Pharmaceutical. Started May 2005; status: completed.
02
Drugs
fentanyl
03
Conditions
Intractable Pain Syndrome (IPS)
Beyond the preview
Go deeper on NCT00216684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216684.